GlassScriptPhysician profile
Randall Lomax
NPI 1306999008
$4,431.24
in general payments reported to CMS, 2019-2025
25 companies · $1,364 in 2025
The $1,364 reported for 2025 was more than what 86% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $532 · 2020: $159 · 2021: $359 · 2022: $581 · 2023: $609 · 2024: $828 · 2025: $1,364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,730 · Education: $70.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,730.41 |
| Education | $70.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $796.40 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $789.43 | 2019-2025 | Dupixent |
| Medtronic, INC. | $685.12 | 2021-2025 | Propel, Pteye Parathyroid Detection System, Sinuva |
| Optinose US, INC. | $392.80 | 2020-2025 | |
| Genzyme Corporation | $367.60 | 2020-2025 | |
| Intersect Ent, INC. | $227.76 | 2019-2022 | |
| Medtronic USA, INC. | $143.39 | 2019-2020 | |
| Aerin Medical INC. | $130.18 | 2019-2025 | |
| Stryker Corporation | $119.85 | 2021-2025 | Xpress Loprofile, Clarifix |
| Acclarent, INC | $109.80 | 2019-2023 | Relieva Tract |
| Inspire Medical Systems, INC. | $90.89 | 2024-2025 | Inspire |
| Kowa Pharmaceuticals America, INC. | $84.40 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $83.22 | 2019 | |
| Sanofi-Aventis U.S. LLC | $75.33 | 2021-2025 | |
| Forte Bio-Pharma LLC | $73.41 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $50.31 | 2025 | Tezspire |
| Arbor Pharmaceuticals, INC. | $36.94 | 2019-2020 | |
| Alk-Abello, INC | $31.75 | 2021-2022 | |
| Kaleo, INC. | $26.90 | 2022 | |
| Paratek Pharmaceuticals, INC. | $23.05 | 2025 | Xhance |
| Ethicon US, LLC | $21.48 | 2019 | |
| Itamar Medical INC | $20.58 | 2025 | Watchpatone |
| Lilly USA, LLC | $18.79 | 2025 | Zepbound |
| Hikma Pharmaceuticals USA | $18.38 | 2023 | Ryaltris |
| Integra Lifesciences Corporation | $13.48 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Lomax listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.